Archive - BowTiedBiotech

Strategic Flexibility in FDA Cell and Gene Therapy Regulation | Ep. 1054

FDA Overhauls Gene Therapy Manufacturing Rules

11 hrs ago

24:31

BIOTECH MARKET RESEARCH $AMLX | Ep. 1053

Amylyx Pharmaceuticals

Aug 11

Programmable Immunity | Ep. 1052

The Real Opportunity in In-Vivo CAR Therapies

Aug 9

BowTiedBiotech: A Constructive Week for the Sector | Ep. 1051

Capital surges in an unforgiving biotech market

Aug 8

25:10

Your Weekly Biotech News Fix | Ep. 1050

The week of 8.3.2026

Aug 7

The Drug Supply Chain Is Running Out of Water | Ep. 1049

Europe’s drought is turning rivers, cooling systems, and industrial water into hidden constraints on therapeutic development

Aug 6

Breaking the Career Ladder: The Future of Entry-Level Work | Ep. 1048

How AI breaks the corporate ladder

Aug 5

22:32

The Last Shot Strategy | Ep. 1047

What Happens When Biotech Goes Virtual to Survive

Aug 2

Biotech Market Review: Clinical Outcomes and Commercial Execution | Ep. 1046

Scientific Theory Versus Brutal Market Reality

Aug 2

26:04

Your Weekly Biotech News Fix | Ep. 1045

The week of 7.27.2026

Aug 2

July 2026

Internal Innovation or Strategic Sourcing? | Ep. 1043

Rethinking Pharma's Growth Engine

Jul 26

BIOTECH MARKET RESEARCH $SLN | Ep. 1044

SIlence Therapeutics

Jul 26

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts